
Palisade Bio, Inc.: updates and filings
Price
$0.84
November 20, 2026Market cap $151M
What Ploutos Investor adds for Palisade Bio
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 26% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.13 then, $0.84 on Nov 20, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 10, 2026next Feb 10, 2027
A rough estimate from when it has reported before, which has varied. The company announces the date itself.
November 2026
August 2026
June 2026
May 2026
April 2026
October 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 10, 2026Results of operationsForm8-K
- Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 9, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 10, 2026Results of operationsForm8-K
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jun 11, 2026Officer or director change, amended articles or bylaws, shareholder voteForm8-K
- Jun 10, 2026Shares registered for employeesFormS-8
- May 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 21, 2026FilingFormEFFECT
- May 19, 2026Correspondence with the SECFormCORRESP
- May 19, 2026Letter from the SECFormUPLOAD
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 12, 2026Shelf registration for future offeringsFormS-3
- May 12, 2026Results of operationsForm8-K
- May 12, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 10, 2026 | 8-K | Results of operations | Document |
| Nov 10, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 9, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jun 11, 2026 | 8-K | Officer or director change, amended articles or bylaws, shareholder vote | Document |
| Jun 10, 2026 | S-8 | Shares registered for employees | Document |
| May 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 21, 2026 | EFFECT | Filing | Document |
| May 19, 2026 | CORRESP | Correspondence with the SEC | Document |
| May 19, 2026 | UPLOAD | Letter from the SEC | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 12, 2026 | S-3 | Shelf registration for future offerings | Document |
| May 12, 2026 | 8-K | Results of operations | Document |
| May 12, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 3, 2006. Of its note and share prospectuses (424B, FWP), the newest 40 of 91.
The full analysis
What do Palisade Bio's filings show?
The filings are where every one of Palisade Bio's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.